Skip to content
  • Home
  • How We Work
    • The Impact of Autophagy in Health and Disease
    • Biophagy’s Business Model
    • Biophagy’s Proprietary Drug Development
    • Cell Watchᵀᴹ
  • Business Development
  • Background & News
  • Team
  • Contact
Previous Next

Mary Ortner, PhD, MBA, accepts the position of president and CEO. She was previously SVP, business development and corporate alliances, at BioXcel Corporation.

By jordan|2022-03-22T20:42:33+00:00February 1, 2022|2013-announcements|0 Comments

Share This Story, Choose Your Platform!

FacebookTwitterRedditLinkedInWhatsAppTelegramTumblrPinterestVkXingEmail

About the Author: jordan

Related Posts

  • Dr. Mary Ortner, Biophagy’s CEO, is elected vice president of the NM Biotechnology and Biomedical Association (NMBio), the BIO-affiliated NM trade association for bioscience in New Mexico.

    Dr. Mary Ortner, Biophagy’s CEO, is elected vice president of the NM Biotechnology and Biomedical Association (NMBio), the BIO-affiliated NM trade association for bioscience in New Mexico.

  • Dr. Steven Bradfute accepts a consulting position with Biophagy. He will advise the company and conduct assays in immunology and virology.

    Dr. Steven Bradfute accepts a consulting position with Biophagy. He will advise the company and conduct assays in immunology and virology.

  • Biophagy signs an option with STC.UNM to license and develop autophagy-related technologies and molecules created at the University of New Mexico

    Biophagy signs an option with STC.UNM to license and develop autophagy-related technologies and molecules created at the University of New Mexico

Leave A Comment Cancel reply

Copyright 2022 | All Rights Reserved | Website Design and Development by Ingenuity Software Labs
FacebookTwitterInstagramPinterest
Page load link
Go to Top